JP2021530443A5 - - Google Patents
Info
- Publication number
- JP2021530443A5 JP2021530443A5 JP2020571382A JP2020571382A JP2021530443A5 JP 2021530443 A5 JP2021530443 A5 JP 2021530443A5 JP 2020571382 A JP2020571382 A JP 2020571382A JP 2020571382 A JP2020571382 A JP 2020571382A JP 2021530443 A5 JP2021530443 A5 JP 2021530443A5
- Authority
- JP
- Japan
- Prior art keywords
- fluoro
- thiadiazolidine
- trione
- alkyl
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023008491A JP7704787B2 (ja) | 2018-06-21 | 2023-01-24 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
| JP2025107930A JP2025143330A (ja) | 2018-06-21 | 2025-06-26 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862688226P | 2018-06-21 | 2018-06-21 | |
| US62/688,226 | 2018-06-21 | ||
| PCT/US2019/038459 WO2019246513A1 (en) | 2018-06-21 | 2019-06-21 | Protein tyrosine phosphatase inhibitors and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023008491A Division JP7704787B2 (ja) | 2018-06-21 | 2023-01-24 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021530443A JP2021530443A (ja) | 2021-11-11 |
| JP2021530443A5 true JP2021530443A5 (https=) | 2022-04-04 |
| JP7217762B2 JP7217762B2 (ja) | 2023-02-03 |
Family
ID=67254011
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020571382A Active JP7217762B2 (ja) | 2018-06-21 | 2019-06-21 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
| JP2023008491A Active JP7704787B2 (ja) | 2018-06-21 | 2023-01-24 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
| JP2025107930A Pending JP2025143330A (ja) | 2018-06-21 | 2025-06-26 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023008491A Active JP7704787B2 (ja) | 2018-06-21 | 2023-01-24 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
| JP2025107930A Pending JP2025143330A (ja) | 2018-06-21 | 2025-06-26 | タンパク質チロシンホスファターゼ阻害剤及びそれらの使用方法 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US10954202B2 (https=) |
| EP (1) | EP3810580A1 (https=) |
| JP (3) | JP7217762B2 (https=) |
| KR (3) | KR102850637B1 (https=) |
| CN (1) | CN112955438A (https=) |
| AR (1) | AR125425A1 (https=) |
| AU (2) | AU2019290197B2 (https=) |
| BR (1) | BR112020026086A2 (https=) |
| CA (1) | CA3104507A1 (https=) |
| CL (1) | CL2020003316A1 (https=) |
| CO (1) | CO2021000447A2 (https=) |
| CR (1) | CR20210017A (https=) |
| DO (1) | DOP2020000252A (https=) |
| EC (1) | ECSP21003520A (https=) |
| IL (1) | IL279587A (https=) |
| MA (1) | MA52963A (https=) |
| MX (2) | MX2020014223A (https=) |
| PE (1) | PE20210372A1 (https=) |
| PH (1) | PH12020552228A1 (https=) |
| SG (1) | SG11202012820PA (https=) |
| TW (2) | TW202600546A (https=) |
| UY (1) | UY38272A (https=) |
| WO (1) | WO2019246513A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190284553A1 (en) | 2018-03-15 | 2019-09-19 | KSQ Therapeutics, Inc. | Gene-regulating compositions and methods for improved immunotherapy |
| BR112020026086A2 (pt) * | 2018-06-21 | 2021-03-23 | Calico Life Sciences Llc | inibidores da proteína tirosina fosfatase e métodos de uso destes |
| IL286373B2 (en) * | 2019-03-14 | 2026-03-01 | Calico Life Sciences Llc | Protein tyrosine phosphate inhibitor compounds and uses thereof |
| CN115003315A (zh) * | 2019-12-04 | 2022-09-02 | 莫纳什大学 | 使用ptp1b和ptpn2抑制剂激活细胞毒性白细胞的方法 |
| EP4073242A4 (en) | 2019-12-12 | 2024-01-03 | Kumquat Biosciences Inc. | Compositions and methods for potentiating immune activity |
| CA3162069A1 (en) * | 2019-12-18 | 2021-06-24 | Elliot P. Farney | Protein tyrosine phosphatase inhibitors and methods of use thereof |
| MX2023002953A (es) * | 2020-09-11 | 2023-06-01 | Calico Life Sciences Llc | Inhibidores de proteína tirosina fosfatasa y métodos para su uso. |
| EP4351558A4 (en) * | 2021-06-10 | 2025-05-07 | Ness Therapeutics, Inc. | Compounds containing 5-(2-fluoro-6-hydroxyphenyl)-1,2,5-thiazolidin-3-one 1,1-dioxide as inhibitors of protein kinase phosphatase enzymes |
| EP4359409A1 (en) * | 2021-06-21 | 2024-05-01 | Calico Life Sciences LLC | Degrader compounds and uses thereof |
| WO2023086498A1 (en) * | 2021-11-11 | 2023-05-19 | Calico Life Sciences Llc | Protein tyrosine phosphatase inhibitors and methods of use thereof |
| MX2024005656A (es) * | 2021-11-11 | 2024-08-06 | Calico Life Sciences Llc | Inhibidores de proteina tirosina fosfatasa y metodos de uso de estos. |
| PE20250780A1 (es) * | 2022-02-02 | 2025-03-14 | Nerio Therapeutics Inc | Inhibidores de proteina tirosina fosfatasa y usos de estos |
| EP4522594A4 (en) * | 2022-05-13 | 2026-04-22 | Mondego Bio Lda A Limited Liability Company By Quotas Soc Por Quotas | PTPN2 INHIBITORS |
| CN115197167B (zh) * | 2022-07-22 | 2023-07-28 | 中国药科大学 | 1,2,4-噻二唑烷-3,5-二酮化合物及其制备方法和应用 |
| CN119790052A (zh) * | 2022-09-13 | 2025-04-08 | 金橘生物科技公司 | 苯并稠合的n-杂环及其用途 |
| KR20250090365A (ko) * | 2022-11-09 | 2025-06-19 | 브리스톨-마이어스 스큅 컴퍼니 | 암 질환의 치료를 위한 단백질 티로신 포스파타제 (ptpn2)의 억제제로서의 인다졸 치환된 1,2,5-티아디아졸리딘 유도체 |
| PE20252789A1 (es) | 2023-05-24 | 2025-12-22 | Kumquat Biosciences Inc | Compuestos heterociclicos y usos de estos |
| CN117343052B (zh) * | 2023-12-04 | 2024-02-06 | 英矽智能科技(上海)有限公司 | 蛋白酪氨酸磷酸酶抑制剂及其应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
| FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
| JP2594486B2 (ja) | 1991-01-15 | 1997-03-26 | アルコン ラボラトリーズ インコーポレイテッド | 局所的眼薬組成物 |
| US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
| CA2463615C (en) | 2001-10-30 | 2011-07-26 | Applied Research Systems Ars Holding N.V. | Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| KR100868587B1 (ko) * | 2002-04-03 | 2008-11-12 | 노파르티스 아게 | Ｐｔｐａｓｅ 1ｂ 억제제로서의 5-치환된1,1-디옥소-1,2,5-티아졸리딘-3-온 유도체 |
| GB0225986D0 (en) * | 2002-11-07 | 2002-12-11 | Astrazeneca Ab | Chemical compounds |
| EP1594497B1 (en) * | 2002-12-30 | 2009-05-27 | Vertex Pharmaceuticals Incorporated | Sulfhydantoins as phosphate isosteres for use as phosphatase inhibitors in the treatment of cancer and autoimmune disorders |
| UA94921C2 (en) | 2005-12-08 | 2011-06-25 | Новартис Аг | 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors |
| CA2629819A1 (en) * | 2005-12-08 | 2007-06-14 | Novartis Ag | 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase) |
| CA2630448A1 (en) * | 2005-12-08 | 2007-06-14 | Novartis Ag | 1,1,3-trioxo-1,2,5-thiadiazolidines and their use as ptp-ases inhibitors |
| UA94724C2 (en) * | 2005-12-08 | 2011-06-10 | Новартис Аг | Thiadiazolidinone derivatives as antidiabetic agents |
| NZ569329A (en) * | 2006-01-30 | 2011-09-30 | Transtech Pharma Inc | Substituted imidazole derivatives and their use as PTPase inhibitors |
| CA2647472A1 (en) * | 2006-03-31 | 2007-10-11 | Novartis Ag | Organic compounds |
| WO2008142198A2 (en) | 2007-05-23 | 2008-11-27 | Valtion Teknillinen Tutkimuskeskus | A method for inhibiting or stimulating angiogenesis in an individual |
| WO2010008852A2 (en) | 2008-06-23 | 2010-01-21 | Taiga Biotechnologies, Inc. | Methods of trea fing λλd methods of diagnosing an immunoproliferative disorder |
| US9217012B2 (en) | 2009-04-08 | 2015-12-22 | Indiana University Research And Technology Corporation | Inhibitors of protein tyrosine phosphatases |
| WO2011057331A1 (en) | 2009-11-11 | 2011-05-19 | Monash University | A method for treating obesity |
| EP2531616A4 (en) | 2010-02-03 | 2013-07-10 | Univ Monash | DIAGNOSIS AND FORECAST ASSAY FOR BREAST CANCER |
| WO2015127548A1 (en) | 2014-02-28 | 2015-09-03 | The Royal Institution For The Advancement Of Learning / Mcgill University | Tc-ptp inhibitors as apc activators for immunotherapy |
| EP3154555A4 (en) | 2014-06-10 | 2018-02-28 | Monash University | Method of producing leukocytes using ptpn2 inhibition for adoptive cell transfer |
| US20180325925A1 (en) | 2015-11-06 | 2018-11-15 | Kyungpook National University Industry-Academic Cooperation Foundation | Composition for prevention or treatment of neuroinflammatory disease, containing protein tyrosine phosphatase inhibitor |
| WO2017078499A2 (ko) | 2015-11-06 | 2017-05-11 | 경북대학교 산학협력단 | 단백질 타이로신 탈인산화효소 억제제를 포함하는 신경염증성 질환의 예방 또는 치료용 조성물 |
| WO2018148378A1 (en) | 2017-02-08 | 2018-08-16 | Dana-Farber Cancer Institute, Inc. | Modulating biomarkers to increase tumor immunity and improve the efficiacy of cancer immunotherapy |
| WO2018227248A1 (en) | 2017-06-13 | 2018-12-20 | Monash University | Methods and compositions for the treatment of obesity |
| WO2019036815A1 (en) | 2017-08-24 | 2019-02-28 | The Royal Institution For The Advancement Of Learning/Mcgill University | ENHANCEMENT OF CD8 + T LYMPHOCYTES FOR ADOPTIVE CELL THERAPY BY INHIBITING PTPN1 (PTP1B) AND PTPN2 (TC-PTP)) |
| BR112020026086A2 (pt) * | 2018-06-21 | 2021-03-23 | Calico Life Sciences Llc | inibidores da proteína tirosina fosfatase e métodos de uso destes |
-
2019
- 2019-06-21 BR BR112020026086-0A patent/BR112020026086A2/pt unknown
- 2019-06-21 TW TW114106492A patent/TW202600546A/zh unknown
- 2019-06-21 KR KR1020237016153A patent/KR102850637B1/ko active Active
- 2019-06-21 EP EP19739482.8A patent/EP3810580A1/en active Pending
- 2019-06-21 WO PCT/US2019/038459 patent/WO2019246513A1/en not_active Ceased
- 2019-06-21 JP JP2020571382A patent/JP7217762B2/ja active Active
- 2019-06-21 MA MA052963A patent/MA52963A/fr unknown
- 2019-06-21 KR KR1020217001743A patent/KR102533477B1/ko active Active
- 2019-06-21 PE PE2020002131A patent/PE20210372A1/es unknown
- 2019-06-21 CN CN201980054332.9A patent/CN112955438A/zh active Pending
- 2019-06-21 SG SG11202012820PA patent/SG11202012820PA/en unknown
- 2019-06-21 MX MX2020014223A patent/MX2020014223A/es unknown
- 2019-06-21 CA CA3104507A patent/CA3104507A1/en active Pending
- 2019-06-21 UY UY0001038272A patent/UY38272A/es unknown
- 2019-06-21 AU AU2019290197A patent/AU2019290197B2/en active Active
- 2019-06-21 CR CR20210017A patent/CR20210017A/es unknown
- 2019-06-21 TW TW108121816A patent/TWI888352B/zh active
- 2019-06-21 KR KR1020257027922A patent/KR20250133466A/ko active Pending
- 2019-06-21 AR ARP190101729A patent/AR125425A1/es unknown
-
2020
- 2020-09-18 US US17/025,644 patent/US10954202B2/en active Active
- 2020-12-18 MX MX2024004318A patent/MX2024004318A/es unknown
- 2020-12-20 IL IL279587A patent/IL279587A/en unknown
- 2020-12-21 DO DO2020000252A patent/DOP2020000252A/es unknown
- 2020-12-21 PH PH12020552228A patent/PH12020552228A1/en unknown
- 2020-12-21 CL CL2020003316A patent/CL2020003316A1/es unknown
-
2021
- 2021-01-18 EC ECSENADI20213520A patent/ECSP21003520A/es unknown
- 2021-01-19 CO CONC2021/0000447A patent/CO2021000447A2/es unknown
-
2023
- 2023-01-24 JP JP2023008491A patent/JP7704787B2/ja active Active
- 2023-11-10 AU AU2023263567A patent/AU2023263567B2/en active Active
-
2025
- 2025-06-26 JP JP2025107930A patent/JP2025143330A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021530443A5 (https=) | ||
| JP2023507774A5 (https=) | ||
| JP6097289B2 (ja) | セリン／スレオニンキナーゼインヒビターとしてのキナゾリン化合物 | |
| JP6985388B2 (ja) | ケモカイン受容体調節剤及びそれの使用 | |
| ES2568220T3 (es) | Imidazopiridazinas sustituidas | |
| TWI793191B (zh) | Ｐ３８激酶抑制劑減少ｄｕｘ４及下游基因表現以供治療ｆｓｈｄ | |
| RU2507204C2 (ru) | Положительные аллостерические модуляторы м1-рецепторов на основе пираниларилметилбензохиназолинона | |
| JP2021523159A5 (https=) | ||
| JP6529492B2 (ja) | 癌の処置のためのｉｄｈ２突然変異体阻害剤としての２，４−または４，６−ジアミノピリミジン化合物 | |
| RU2007129090A (ru) | Органические соединения | |
| TW201803854A (zh) | 經胺取代之芳基或雜芳基化合物 | |
| CN110292579A (zh) | 用于制备抗癌剂al3818、其结晶形式和其盐的方法 | |
| UA122387C2 (uk) | Терапевтично активні сполуки та способи їх застосування | |
| AU2013227024A1 (en) | Novel piperidine compound or salt thereof | |
| AU2013286894A1 (en) | Heterocyclic modulators of lipid synthesis | |
| JP2022551422A5 (https=) | ||
| AU2008300483A1 (en) | Inhibitors of the interaction between MDM2 and p53 | |
| WO2023284838A1 (zh) | Aak1抑制剂及其用途 | |
| RU2010102992A (ru) | Лиганды каннабиноидных рецепторов | |
| RU2013157374A (ru) | Производное индазола и пирролопиридина и его фармацевтическое применение | |
| JP2013532711A (ja) | ピラゾロフェニル−ベンゼンスルホンアミド化合物の誘導体及びその抗腫瘍薬としての使用 | |
| CN107848974A (zh) | 芳族磺酰胺衍生物 | |
| TW201920153A (zh) | 具有環狀構造的化合物 | |
| JP2009522226A (ja) | レニン阻害剤としての３，５−置換ピペリジン化合物 | |
| TWI910207B (zh) | 用於抑制ezh2之化合物及組成物 |